期刊文献+

不同部位前列腺癌超声造影增强程度的定量研究 被引量:12

Quantitative evaluation of enhancement degree of prostate cancer with different location on contrast-enhanced transrectal ultrasonography
原文传递
导出
摘要 目的探讨前列腺癌经直肠超声造影增强程度与部位的相关性。方法对150例前列腺癌可疑患者行经直肠超声造影检查,并运用时间-强度曲线分析软件对病灶增强的峰值强度(peak intensity,PI)进行定量测量,比较前列腺周缘区内侧、周缘区外侧及移行区的PI值差异。结果150例患者中,前列腺癌96例,前列腺增生54例。前列腺癌组病灶PI值大于前列腺增生组[(9.88±3.76)dB对(8.74±4.52)dB,P〈0.01]。前列腺周缘区内侧、周缘区外侧和移行区癌灶的PI值逐渐升高[(6.55±2.90)dB对(10.57±2.52)dB对(13.64±2.38)dB,P〈0.001]。前列腺癌PI值和部位的相关系数为0.718(P〈0.001)。以Gleason评分作为协变量,两者偏相关系数为0.720(P〈0.001)。结论不同部位前列腺癌的增强强度存在差异,明确不同部位前列腺癌增强程度的差异有助于进一步提高超声造影对前列腺癌的诊断敏感性及特异性。 Objective To analyze the enhancement degree of prostate cancer on contrast-enhanced transrectal ultrasonography (CETRUS) in relation to tumor location. Methods 150 patients suspected of prostate cancer were evaluated with CETRUS. The degree of enhancement of the lesions was objectively measured using peak intensity (PI) with time-intensity curve analysis software. The peak intensity of the lesions located in the medial peripheral zone, the lateral peripheral zone and the transition zone was compared and analyzed. Results Prostate cancer was detected in 96 of 150 patients. The mean PI value of the prostate cancer was significantly higher than that of the benign prostate hyperplasia lesions [(9.88±3.76) dB vs (8.74 ± 4.52)dB, P〈0.01]. The PI value of the cancer loci located in the medial peripheral zone, the lateral peripheral zone and the transition zone increased gradually [(6.55 ± 2.90)dB vs (10.57 ± 2.52)dB vs (13.64 ± 2.38)dB, P〈0. 001]. The Spearman correlation coefficient between the tumor location and the PI value was 0. 718 ( P〈0. 001). The partial correlation coefficient was 0. 720 when the Gleason score was used as a covariate ( P 〈 0. 001). Conclusions There was significant difference in enhancement degree between prostate cancer lesions with different location. Being aware of this might be valuable for improving the sensitivity and specificity of CEUS in diagnosis of the prostate cancer.
出处 《中华超声影像学杂志》 CSCD 北大核心 2012年第11期977-981,共5页 Chinese Journal of Ultrasonography
基金 上海市科委医学重点项目(10411952000) 上海市科委面上项目(09411963800) 上海交通大学医工交叉研究基金项目(YG2011MS43) 上海交通大学医学院科技基金项目(11XJ21019)
关键词 超声检查 微气泡 前列腺肿瘤 Ultrasonography Microbubbles Prostatic neoplasms
  • 相关文献

参考文献17

  • 1Arita J, Takahashi M, Hata S, et al. Usefulness of contrast- enhanced intraoperative ultrasound using Sonazoid in patients with hepatocellular carcinoma. Ann Surg, 2011,254 992-999.
  • 2Wang X, Xu P, Wang Y, et al. Contrast-enhanced ultrasonographle findings of different histopathologic types of breast cancer. Acta Radiol, 2011,52 : 248-255.
  • 3Smeenge M, Mischi M, Laguna Pes MP, et al. Novel contrast- enhanced ultrasound imaging in prostate cancer. World J Urol, 2011,29:581-587.
  • 4Tang J, Yang JC, Luo Y, et al. Enhancement characteristics of benign and malignant focal peripheral nodules in the peripheral zone of the prostate gland studied using contrast-enhanced transrectal ultrasound. Clin Radiol, 2008,63 : 1086-1091.
  • 5Mitterherger M, Horninger W, Pelzer A, et al. A prospective randomized trial comparing contrast-enhanced targeted versus systematic ultrasound guided biopsies zimpact on prostate cancer detection. Prostate, 2007,67 : 1537-1542.
  • 6Zhu Y, Chen Y, Jiang J, et al. Contrast-enhanced harmonic ultrasonography for the assessment of prostate cancer aggressiveness:a preliminary study. Korean J Radiol,2010, 11: 75-83.
  • 7Zhu Y,Chen Y, Qi T, et al. Prostate cancer detection with real- time elastography using a hi-plane transducer: comparison with step section radical prostateetomy pathology. World J Urol, 2012. [-Epub ahead of printS.
  • 8Ngo TC, Conti SL, Shinghal R, et al. Prostate size does not predict high grade cancer. J Urol, 2012,187 : 477-480.
  • 9Cosgrove D. Ultrasound contrast agents: an overview. Eur J Radiol,2006,60:324 330.
  • 10Quaia E. Microbubble ultrasound contrast agents:an update. Eur Radiol, 2007,17 : 1995-2008.

二级参考文献16

  • 1Rosenthal SA,Sandler HM.Treatment strategies for high-risk locall advanced prostate cancer. Nat Rev Urol . 2010
  • 2Seitz M,Gratzke C,Schlenker B,et al.Contrast-enhanced transrectal ultrasound (CE-TURS)with cadence-contrast pulse sequence (CPS)technology for the identification of prostate cancer. Urologic Oncology . 2009
  • 3Forsberg F,Merton DA,Liu JB,et al.Clinical applications of ultrasound contrast agents. Ultrasonics . 1998
  • 4Borre M,Offersen BV,Nerstrom B,et al.Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting. British Journal of Cancer . 1998
  • 5Bono AV,Celato N,Cova V,et al.Microvessel density in prostatecarcinoma. Prostate Cancer and Prostatic Diseases . 2002
  • 6Weidner N,Carroll PR,Flax J,et al.Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. American Journal of Pathology . 1993
  • 7McNeal JE,Redwine EA,Freiha FS,et al.Zonal distribution of prostatic adenocarcinoma: correlation with histologic pattern and direction of spread. American Journal of Surgical Pathology, The . 1988
  • 8A Jemal.Cancer statistics, 2009. CA A Cancer Journal for Clinicians . 2009
  • 9Mitterberger M,Pinggera G,Horninger W,et al.Comparison of contrastenhanced colour Doppler targeted biopsy to conventional systematic biopsy mpact on Gleason score. Journal d Urologie . 2007
  • 10Stark JR,Perner S,Stampfer MJ,Sinnott JA,Finn S,Eisenstein AS,Ma J,Fiorentino M,Kurth T,Loda M et al.Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?. Journal of Clinical Oncology . 2009

共引文献50

同被引文献141

引证文献12

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部